OptiNose Inc (NASDAQ: OPTN) has seen a decline in its stock price by -1.79 in relation to its previous close of 0.85. However, the company has experienced a -10.72% decline in its stock price over the last five trading sessions. globenewswire.com reported 2024-09-05 that YARDLEY, Pa., Sept. 05, 2024 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the peer-review publication of a paper titled, “EDS-FLU efficacy in patients with chronic rhinosinusitis with or without prior sinus surgery in ReOpen1 and ReOpen2 randomized controlled trials”1 in the International Forum of Allergy & Rhinology, the journal of the American Rhinologic Society.
Is It Worth Investing in OptiNose Inc (NASDAQ: OPTN) Right Now?
Company’s 36-month beta value is -0.02.Analysts have differing opinions on the stock, with 3 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for OPTN is 119.07M, and currently, short sellers hold a 5.89% ratio of that floaft. The average trading volume of OPTN on September 19, 2024 was 729.15K shares.
OPTN’s Market Performance
OPTN’s stock has seen a -10.72% decrease for the week, with a -10.43% drop in the past month and a -26.12% fall in the past quarter. The volatility ratio for the week is 5.37%, and the volatility levels for the past 30 days are at 5.61% for OptiNose Inc The simple moving average for the past 20 days is -12.43% for OPTN’s stock, with a -30.97% simple moving average for the past 200 days.
Analysts’ Opinion of OPTN
Many brokerage firms have already submitted their reports for OPTN stocks, with H.C. Wainwright repeating the rating for OPTN by listing it as a “Buy.” The predicted price for OPTN in the upcoming period, according to H.C. Wainwright is $5 based on the research report published on March 11, 2024 of the current year 2024.
Lake Street, on the other hand, stated in their research note that they expect to see OPTN reach a price target of $3. The rating they have provided for OPTN stocks is “Buy” according to the report published on August 21st, 2023.
Jefferies gave a rating of “Buy” to OPTN, setting the target price at $5 in the report published on October 21st of the previous year.
OPTN Trading at -16.78% from the 50-Day Moving Average
After a stumble in the market that brought OPTN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -60.25% of loss for the given period.
Volatility was left at 5.61%, however, over the last 30 days, the volatility rate increased by 5.37%, as shares sank -10.22% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -24.09% lower at present.
During the last 5 trading sessions, OPTN fell by -10.70%, which changed the moving average for the period of 200-days by -33.73% in comparison to the 20-day moving average, which settled at $0.9485. In addition, OptiNose Inc saw -35.29% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at OPTN starting from Marino Michael F III, who sale 3,226 shares at the price of $0.87 back on Sep 17 ’24. After this action, Marino Michael F III now owns 547,238 shares of OptiNose Inc, valued at $2,807 using the latest closing price.
Mahmoud Ramy A, the Chief Executive Officer of OptiNose Inc, sale 4,881 shares at $0.87 during a trade that took place back on Sep 17 ’24, which means that Mahmoud Ramy A is holding 1,202,097 shares at $4,246 based on the most recent closing price.
Stock Fundamentals for OPTN
Current profitability levels for the company are sitting at:
- -0.25 for the present operating margin
- 0.9 for the gross margin
The net margin for OptiNose Inc stands at -0.55. The total capital return value is set at -0.19.
Based on OptiNose Inc (OPTN), the company’s capital structure generated 1.51 points at debt to capital in total, while cash flow to debt ratio is standing at -0.28. The debt to equity ratio resting at -2.94. The interest coverage ratio of the stock is -0.94.
Currently, EBITDA for the company is -22.35 million with net debt to EBITDA at -1.88. When we switch over and look at the enterprise to sales, we see a ratio of 2.09. The receivables turnover for the company is 3.61for trailing twelve months and the total asset turnover is 0.57. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.94.
Conclusion
In a nutshell, OptiNose Inc (OPTN) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
